EV/EBITDA Ratio: 13.61x

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 13.61x is in line with its estimated 1-year average of 14.91x, near the low end of its estimated 1-year range (12.67x–17.24x).

As of 2026-09-15T17:05:43.993Z.

MDLN EV/EBITDA Ratio Metrics

EV/EBITDA vs. estimated history

At 13.6, EV/EBITDA is below its estimated 1-year median — higher than 12% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Medline Inc. (MDLN)?

The EV/EBITDA ratio for MDLN stock is 13.61x.

Is Medline Inc.'s EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 13.61x is in line with its estimated 1-year average of 14.91x, near the low end of its estimated 1-year range (12.67x–17.24x).

Related Metrics